Pinnacle Financial Partners (Tennessee)’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5
Closed -$2.51K 535
2023
Q2
$2.51K Hold
5
﹤0.01% 532
2023
Q1
$2.5K Hold
5
﹤0.01% 525
2022
Q4
$2.04K Buy
+5
New +$1.94K ﹤0.01% 519
2017
Q3
Sell
-205
Closed -$33K 361
2017
Q2
$33K Buy
+205
New +$33.3K ﹤0.01% 368

Other funds holding IDXX

Pinnacle Financial Partners (Tennessee)'s IDXX Position: Q3 2023 in Review

Pinnacle Financial Partners (Tennessee) sold out of Idexx Laboratories (IDXX) in Q3 2023, closing a stake of 5 shares — an estimated $2.51K sold.

Pinnacle Financial Partners (Tennessee) first reported a position in IDXX in Q2 2017 and held it in 4 quarters. The position peaked at $33K in Q2 2017. 1,060 funds tracked by Wall St. Rank hold IDXX as of Q3 2023.

  • Pinnacle Financial Partners (Tennessee) reported no remaining Idexx Laboratories position as of Q3 2023 after selling out during the quarter.
  • Pinnacle Financial Partners (Tennessee) sold 5 Idexx Laboratories shares in Q3 2023, an estimated $2.51K.
  • Pinnacle Financial Partners (Tennessee) first reported a position in Idexx Laboratories in Q2 2017 and held it in 4 quarters.
  • Pinnacle Financial Partners (Tennessee)'s Idexx Laboratories position peaked at $33K in Q2 2017.
  • 1,060 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2023.

Based on Pinnacle Financial Partners (Tennessee)'s 13F filing for Q3 2023, filed 3 Nov 2023.